{
    "nctId": "NCT00046891",
    "briefTitle": "EGb761 in Maintaining Mental Clarity in Women Receiving Chemotherapy for Newly Diagnosed Breast Cancer",
    "officialTitle": "The Use of Ginkgo Biloba For The Prevention Of Chemotherapy-Related Cognitive Dysfunction",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer, Neurotoxicity",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE3",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "SUPPORTIVE_CARE",
    "enrollmentCount": 226,
    "primaryOutcomeMeasure": "The Level of Cognitive Dysfunction as Measured by the High Sensitivity Cognitive Screen (HSCS) Overall Score.",
    "eligibilityCriteria": "DISEASE CHARACTERISTICS:\n\n* Newly diagnosed breast cancer\n* Planned standard doses of adjuvant chemotherapy with or without a taxane\n\nPATIENT CHARACTERISTICS:\n\nAge\n\n* 18 and over\n\nSex\n\n* Female\n\nMenopausal status\n\n* Any status\n\nPerformance status\n\n* Eastern Cooperative Oncology Group (ECOG) 0-1\n\nLife expectancy\n\n* At least 6 months\n\nHematopoietic\n\n* No bleeding diathesis\n\nHepatic\n\n* serum glutamate oxaloacetate transaminase (SGOT) no greater than 1.5 times upper limit of normal (ULN)\n* Alkaline phosphatase no greater than 1.5 times ULN\n\nRenal\n\n* Creatinine no greater than 1.5 times ULN\n\nCardiovascular\n\n* No arterial vascular disease\n\nOther\n\n* Able to complete questionnaires alone or with assistance\n* No diabetes\n* No dementia\n* No diagnosis of a psychiatric disorder within the past 5 years that would preclude study compliance\n* No other significant comorbidity\n* No known allergy to ginkgo biloba\n* Not pregnant or nursing\n* Negative pregnancy test\n* Fertile patients must use effective contraception\n\nPRIOR CONCURRENT THERAPY:\n\nBiologic therapy\n\n* No concurrent stem cell transplantation\n\nChemotherapy\n\n* No concurrent high-dose chemotherapy\n\nOther\n\n* More than 6 months since prior EGb761\n* No concurrent antithrombotic therapy (e.g., daily aspirin or anticoagulants)\n\n  * Anticoagulants used for central or peripheral line maintenance (i.e., warfarin 1 mg/day or heparin flushes) allowed\n* No concurrent dose-intensive regimens\n* No concurrent aspirin or aspirin-like medicines (e.g., indomethacin, ibuprofen, or some antihistamines or heparin or warfarin \\[except as used above\\])\n* No concurrent regimen expected to cause thrombocytopenia\n* No concurrent trazodone, monoamine oxidase inhibitors, or thiazide diuretics (e.g., chlorothiazide, hydrochlorothiazide, indapamide, or metolazone)",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}